Malaria Vaccines Market Size, Share, Trends, Industry Analysis Report: By Vaccine Type, Administration Route, Target Population, Immunization Schedule, Development Stage, and Region

Description

List of Tables

The global malaria vaccines market size is expected to reach USD 1,619.87 million by 2034, according to a new study by Polaris Market Research. The report "Malaria Vaccines Market Size, Share, Trends, Industry Analysis Report: By Vaccine Type, Administration Route (Subcutaneous and Intramuscular), Target Population, Immunization Schedule, Development Stage, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Malaria is a serious, life-threatening disease caused by Plasmodium parasite, which is transmitted from human to human by the bite of infected mosquitoes. This mosquito-borne illness causes severe disease in kids and adults. Pregnant women and children are particularly vulnerable to the fever caused by malaria. Various precautions to control the disease include the use of insect nets and spraying of pesticides. However, current research studies have shown that insects are immune to pesticides, pesticides have harmful effects on human beings, and malaria fever is becoming immune to medications. In response to these challenges, researchers and pharmaceutical companies have been working on the development of malaria vaccines as an alternative method of prevention.

Several factors, such as the rising incidence of malaria worldwide and the introduction of low-cost malaria vaccines by pharma companies globally, are driving the malaria vaccines market growth. Rising awareness about the disease's consequences and ongoing research and development (R&D) initiatives are further supporting the market development.

Growing efforts by government and private organizations to address the issues of weak supply chains and distribution networks in some malaria-endemic developing countries are expected to boost the adoption of malaria vaccines. Rising inoculation programs and emphasis on the development of innovative vaccine technologies are expected to provide several malaria vaccines market opportunities in the coming years.

Key Highlights of Malaria Vaccines Market Report

Based on vaccine type, the RTS,S/AS01 segment held the largest share of the malaria vaccines market revenue in 2024, owing to the extensive clinical research and trials demonstrating the efficacy of RTS, S/AS01 vaccines, and their rollout in various African countries.

By administration route, the intramuscular segment led the malaria vaccines market share in 2024 as intramuscular is the most widely used route for administrating malaria vaccines, including R21/Matrix-M and RTS,S/AS01.

North America led the market for malaria vaccines in 2024, driven by the strong presence of leading pharma companies with significant investments in malaria vaccine development programs and the introduction of favorable government regulations supporting malaria vaccine R&D initiatives.

The Middle East & Africa malaria vaccines market is projected to witness a significant CAGR from 2025 to 2034, driven by the rising focus on improving healthcare infrastructure and enhanced collaborations between government and private organizations to develop cost-effective malaria vaccines.

Instituto Butantan, Merck, PATH, GSK, Vaxart, Biovac, Pfizer, Inovio Pharmaceuticals, Bharat Biotech, University of Oxford, Intellia Therapeutics, Johnson & Johnson, Sanaria, and Takeda Pharmaceutical Company are a few of the key players in the market.

Polaris Market Research has segmented the malaria vaccines market research report on the basis of vaccine type, administration route, target population, immunization schedule, development stage, and region:

By Vaccine Type Outlook (Revenue - USD Million, 2020-2034)

PfSPZ
RTS,S/AS01
R21/Matrix-M

By Administration Route Outlook (Revenue - USD Million, 2020-2034)

Subcutaneous
Intramuscular

By Target Population Outlook (Revenue - USD Million, 2020-2034)

Travelers to Endemic Areas
Pregnant Women
Children under 5 Years

By Immunization Schedule Outlook (Revenue - USD Million, 2020-2034)

Single Dose
Multi-Dose
Booster Doses

By Development Stage Outlook (Revenue - USD Million, 2020-2034)

Preclinical
Clinical Trials

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1525

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Malaria Vaccines Market Insights

4.1. Malaria Vaccines Market - Application Snapshot
4.2. Malaria Vaccines Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Prevalence of Malaria in Low-Income Countries
  - 4.2.1.2. Increasing Funding and Investment
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Drug Development and Distribution
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry Among Existing Firms (High)
4.4. PESTEL Analysis
4.5. Malaria Vaccines Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Malaria Vaccines Market, by Vaccine Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
5.3. PfSPZ
- 5.3.1. Global Malaria Vaccines Market, by PfSPZ, by Region, 2020-2034 (USD Million)
5.4. RTS,S/AS01
- 5.4.1. Global Malaria Vaccines Market, by RTS,S/AS01, by Region, 2020-2034 (USD Million)
5.5. R21/Matrix-M
- 5.5.1. Global Malaria Vaccines Market, by R21/Matrix-M, by Region, 2020-2034 (USD Million)

6. Global Malaria Vaccines Market, by Administration Route

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
6.3. Subcutaneous
- 6.3.1. Global Malaria Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
6.4. Intramuscular
- 6.4.1. Global Malaria Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)

7. Global Malaria Vaccines Market, by Target Population

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
7.3. Travelers to Endemic Areas
- 7.3.1. Global Malaria Vaccines Market, by Travelers to Endemic Areas, by Region, 2020-2034 (USD Million)
7.4. Pregnant Women
- 7.4.1. Global Malaria Vaccines Market, by Pregnant Women, by Region, 2020-2034 (USD Million)
7.5. Children Under 5 years
- 7.5.1. Global Malaria Vaccines Market, by Children Under 5 years, by Region, 2020-2034 (USD Million)

8. Global Malaria Vaccines Market, by Immunization Schedule

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
8.3. Single Dose
- 8.3.1. Global Malaria Vaccines Market, by Single Dose, by Region, 2020-2034 (USD Million)
8.4. Multi-Dose
- 8.4.1. Global Malaria Vaccines Market, by Multi-Dose, by Region, 2020-2034 (USD Million)
8.5. Booster Doses
- 8.5.1. Global Malaria Vaccines Market, by Booster Doses, by Region, 2020-2034 (USD Million)

9. Global Malaria Vaccines Market, by Development Stage

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
9.3. Preclinical
- 9.3.1. Global Malaria Vaccines Market, by Preclinical, by Region, 2020-2034 (USD Million)
9.4. Clinical Trials
- 9.4.1. Global Malaria Vaccines Market, by Clinical Trials, by Region, 2020-2034 (USD Million)

10. Global Malaria Vaccines Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Malaria Vaccines Market Assessment, by Geography, 2020-2034 (USD Million)
10.3. Malaria Vaccines Market - North America
- 10.3.1. North America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
- 10.3.2. North America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
- 10.3.3. North America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
- 10.3.4. North America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
- 10.3.5. North America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.3.6. Malaria Vaccines Market - US
  - 10.3.6.1. US: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.3.6.2. US: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.3.6.3. US: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.3.6.4. US: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.3.6.5. US: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.3.7. Malaria Vaccines Market - Canada
  - 10.3.7.1. Canada: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.3.7.2. Canada: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.3.7.3. Canada: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.3.7.4. Canada: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.3.7.5. Canada: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
10.4. Malaria Vaccines Market - Europe
- 10.4.1. Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
- 10.4.2. Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
- 10.4.3. Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
- 10.4.4. Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
- 10.4.5. Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.6. Malaria Vaccines Market - UK
  - 10.4.6.1. UK: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.6.2. UK: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.6.3. UK: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.6.4. UK: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.6.5. UK: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.7. Malaria Vaccines Market - France
  - 10.4.7.1. France: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.7.2. France: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.7.3. France: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.7.4. France: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.7.5. France: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.8. Malaria Vaccines Market - Germany
  - 10.4.8.1. Germany: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.8.2. Germany: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.8.3. Germany: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.8.4. Germany: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.8.5. Germany: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.9. Malaria Vaccines Market - Italy
  - 10.4.9.1. Italy: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.9.2. Italy: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.9.3. Italy: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.9.4. Italy: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.9.5. Italy: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.10. Malaria Vaccines Market - Spain
  - 10.4.10.1. Spain: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.10.2. Spain: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.10.3. Spain: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.10.4. Spain: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.10.5. Spain: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.11. Malaria Vaccines Market - Netherlands
  - 10.4.11.1. Netherlands: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.11.2. Netherlands: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.11.3. Netherlands: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.11.4. Netherlands: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.11.5. Netherlands: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.12. Malaria Vaccines Market - Russia
  - 10.4.12.1. Russia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.12.2. Russia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.12.3. Russia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.12.4. Russia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.12.5. Russia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.4.13. Malaria Vaccines Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.4.13.2. Rest of Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.4.13.3. Rest of Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.4.13.4. Rest of Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.4.13.5. Rest of Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
10.5. Malaria Vaccines Market - Asia Pacific
- 10.5.1. Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
- 10.5.2. Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
- 10.5.3. Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
- 10.5.4. Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
- 10.5.5. Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.6. Malaria Vaccines Market - China
  - 10.5.6.1. China: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.6.2. China: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.6.3. China: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.6.4. China: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.6.5. China: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.7. Malaria Vaccines Market - India
  - 10.5.7.1. India: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.7.2. India: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.7.3. India: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.7.4. India: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.7.5. India: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.8. Malaria Vaccines Market - Malaysia
  - 10.5.8.1. Malaysia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.8.2. Malaysia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.8.3. Malaysia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.8.4. Malaysia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.8.5. Malaysia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.9. Malaria Vaccines Market - Japan
  - 10.5.9.1. Japan: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.9.2. Japan: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.9.3. Japan: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.9.4. Japan: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.9.5. Japan: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.10. Malaria Vaccines Market - Indonesia
  - 10.5.10.1. Indonesia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.10.2. Indonesia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.10.3. Indonesia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.10.4. Indonesia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.10.5. Indonesia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.11. Malaria Vaccines Market - South Korea
  - 10.5.11.1. South Korea: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.11.2. South Korea: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.11.3. South Korea: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.11.4. South Korea: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.11.5. South Korea: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.12. Malaria Vaccines Market - Australia
  - 10.5.12.1. Australia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.12.2. Australia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.12.3. Australia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.12.4. Australia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.12.5. Australia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.5.13. Malaria Vaccines Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.5.13.2. Rest of Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.5.13.3. Rest of Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.5.13.4. Rest of Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.5.13.5. Rest of Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
10.6. Malaria Vaccines Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
- 10.6.2. Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
- 10.6.3. Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
- 10.6.4. Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
- 10.6.5. Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.6.6. Malaria Vaccines Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.6.6.2. Saudi Arabia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.6.6.3. Saudi Arabia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.6.6.4. Saudi Arabia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.6.6.5. Saudi Arabia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.6.7. Malaria Vaccines Market - UAE
  - 10.6.7.1. UAE: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.6.7.2. UAE: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.6.7.3. UAE: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.6.7.4. UAE: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.6.7.5. UAE: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.6.8. Malaria Vaccines Market - Israel
  - 10.6.8.1. Israel: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.6.8.2. Israel: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.6.8.3. Israel: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.6.8.4. Israel: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.6.8.5. Israel: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.6.9. Malaria Vaccines Market - South Africa
  - 10.6.9.1. South Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.6.9.2. South Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.6.9.3. South Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.6.9.4. South Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.6.9.5. South Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.6.10. Malaria Vaccines Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.6.10.2. Rest of Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.6.10.3. Rest of Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.6.10.4. Rest of Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.6.10.5. Rest of Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
10.7. Malaria Vaccines Market - Latin America
- 10.7.1. Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
- 10.7.2. Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
- 10.7.3. Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
- 10.7.4. Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
- 10.7.5. Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.7.6. Malaria Vaccines Market - Mexico
  - 10.7.6.1. Mexico: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.7.6.2. Mexico: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.7.6.3. Mexico: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.7.6.4. Mexico: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.7.6.5. Mexico: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.7.7. Malaria Vaccines Market - Brazil
  - 10.7.7.1. Brazil: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.7.7.2. Brazil: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.7.7.3. Brazil: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.7.7.4. Brazil: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.7.7.5. Brazil: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.7.8. Malaria Vaccines Market - Argentina
  - 10.7.8.1. Argentina: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.7.8.2. Argentina: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.7.8.3. Argentina: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.7.8.4. Argentina: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.7.8.5. Argentina: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
- 10.7.9. Malaria Vaccines Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  - 10.7.9.2. Rest of Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  - 10.7.9.3. Rest of Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  - 10.7.9.4. Rest of Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  - 10.7.9.5. Rest of Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Instituto Butantan
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Merck
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. PATH
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. GSK
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. Vaxart
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Biovac
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Pfizer
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Inovio Pharmaceuticals
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Bharat Biotech
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. University of Oxford
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Intellia Therapeutics
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Johnson & Johnson
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
12.13. Sanaria
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
12.14. Takeda Pharmaceutical Company
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development